1. Home
  2. TXG vs SDGR Comparison

TXG vs SDGR Comparison

Compare TXG & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • SDGR
  • Stock Information
  • Founded
  • TXG 2012
  • SDGR 1990
  • Country
  • TXG United States
  • SDGR United States
  • Employees
  • TXG N/A
  • SDGR N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • SDGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TXG Industrials
  • SDGR Health Care
  • Exchange
  • TXG Nasdaq
  • SDGR Nasdaq
  • Market Cap
  • TXG 1.6B
  • SDGR 1.4B
  • IPO Year
  • TXG 2019
  • SDGR 2020
  • Fundamental
  • Price
  • TXG $11.76
  • SDGR $20.15
  • Analyst Decision
  • TXG Buy
  • SDGR Buy
  • Analyst Count
  • TXG 12
  • SDGR 8
  • Target Price
  • TXG $13.54
  • SDGR $27.25
  • AVG Volume (30 Days)
  • TXG 2.7M
  • SDGR 1.1M
  • Earning Date
  • TXG 10-28-2025
  • SDGR 11-11-2025
  • Dividend Yield
  • TXG N/A
  • SDGR N/A
  • EPS Growth
  • TXG N/A
  • SDGR N/A
  • EPS
  • TXG N/A
  • SDGR N/A
  • Revenue
  • TXG $644,466,000.00
  • SDGR $237,917,000.00
  • Revenue This Year
  • TXG $2.15
  • SDGR $22.63
  • Revenue Next Year
  • TXG N/A
  • SDGR $19.77
  • P/E Ratio
  • TXG N/A
  • SDGR N/A
  • Revenue Growth
  • TXG 2.02
  • SDGR 18.59
  • 52 Week Low
  • TXG $6.78
  • SDGR $16.60
  • 52 Week High
  • TXG $20.92
  • SDGR $28.47
  • Technical
  • Relative Strength Index (RSI)
  • TXG 41.80
  • SDGR 51.94
  • Support Level
  • TXG $11.22
  • SDGR $20.44
  • Resistance Level
  • TXG $13.22
  • SDGR $22.03
  • Average True Range (ATR)
  • TXG 0.57
  • SDGR 0.94
  • MACD
  • TXG 0.00
  • SDGR 0.18
  • Stochastic Oscillator
  • TXG 27.18
  • SDGR 47.45

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: